Cure My Disease

Don't miss your cure!

 Log in / Sign up

New stent study aims for faster healing in High-Risk heart patients

NCT ID NCT07230847

Recruiting now Disease control Sponsor: China National Center for Cardiovascular Diseases Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at two types of stents (small mesh tubes) placed in heart arteries to keep them open. It focuses on patients with acute coronary syndrome who also have a high risk of bleeding. The goal is to see how well the blood vessel heals around the stent one month after the procedure, using a special imaging technique called OCT. About 60 participants will be enrolled, and the results will help doctors understand which stent might be safer and more effective for this vulnerable group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
BA9 (sirolimus derivative) coated on BioFreedom stent
What this could lead to
If successful, this could show that the BioFreedom stent helps blood vessels heal faster and safer in patients with high bleeding risk, potentially reducing complications.
What could go wrong
This is a small, early-stage study with only 60 participants, so results may not apply to everyone. The main risk is that the stent might not heal as well as expected, leading to blood clots or other issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute coronary syndrome coronary artery disorder Coronary Disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE CORONARY SYNDROME CORONARY HEART DISEASE

Contacts and locations

Locations

  • Fuwai hospital, CAMS&PUMC

    RECRUITING

    Beijing, Beijing Municipality, 100037, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.